FDA Clearance Tracker · P080012-S003
PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
Last checked: Nov 20, 2026Latest source record: May 4, 2012 (this decision)Source: openFDAMethods & limitations
Decided
May 4, 2012
Approved
Time to decision
59 days
Received Mar 6, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080012-S003
- Device name
- PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
- Applicant
- Infusyn Therapeutics, LLC
- Applicant location
- Hackettstown, NJ
- Received
- Mar 6, 2012
- Decided
- May 4, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P080012
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Infusyn Therapeutics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S068 · Decided Jan 12, 2022 · 433 days after receipt · Panel Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.